SILO PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
SILO PHARMA, INC. (SILO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.88 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-08-13
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.88M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $827.13K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $725.24K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-06-30 | $1.88M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $827.13K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $725.24K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |